Healthy high growth potential

Results

1515

Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.

1515 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
MDGL
US$482.00-10.5%42.2%US$11.1bUS$682.938.763.7%n/aPharmaceuticals & Biotech
FWRY
ج.م18.93-0.3%47.3%ج.م64.5bج.م22.4524.227.3%n/aDiversified Financials
SAUD3
R$16.097.7%30.8%R$47.0bR$17.2783.342.0%5.1%Healthcare
CORT
US$112.8019.8%60.1%US$12.2bUS$135.25224.744.8%n/aPharmaceuticals & Biotech
NVDA
US$206.644.9%15.9%US$5.0tUS$302.8331.422.8%0.5%Semiconductors
LITE
US$779.8919.6%621.1%US$60.7bUS$1,104.89138.256.5%n/aTech
CRDO
US$218.3513.6%98.0%US$40.7bUS$279.2986.227.7%n/aSemiconductors
AXSM
US$211.04-9.9%103.7%US$10.9bUS$282.3215.357.0%n/aPharmaceuticals & Biotech
MOD
US$195.92-5.8%39.4%US$10.4bUS$310.2972.251.3%n/aCapital Goods
543273
₹2,527.750.3%198.8%₹61.8b₹2,500.0078.453.9%n/aTransportation
SAATVIKGL
₹426.30-2.6%n/a₹54.2b₹542.5015.239.6%n/aSemiconductors
2368
NT$897.0010.9%144.7%NT$453.3bNT$1,576.8840.038.2%1.1%Tech
2480
HK$14.00-0.6%-39.5%HK$2.8bHK$31.003.677.1%n/aPharmaceuticals & Biotech
300432
CN¥16.094.6%25.2%CN¥27.5bCN¥34.4054.360.7%0.6%Automobiles
SKS
AU$8.6418.7%277.3%AU$996.8mAU$9.9758.242.9%0.7%Capital Goods
688270
CN¥63.034.2%63.7%CN¥18.9bCN¥185.71125.685.5%0%Semiconductors
AV1
AU$0.08322.1%-42.8%AU$76.9mAU$0.168.0107.8%n/aSoftware
1357
HK$4.8221.1%-56.3%HK$21.9bHK$8.9725.831.3%2.1%Media
605376
CN¥143.325.0%244.2%CN¥37.5bCN¥120.50154.345.7%0.07%Materials
688700
CN¥52.16-5.4%16.9%CN¥15.5bCN¥53.67104.957.4%0.4%Capital Goods
002709
CN¥37.11-0.5%94.7%CN¥75.3bCN¥65.0826.328.3%0.7%Materials
688300
CN¥111.18-6.4%105.7%CN¥26.8bCN¥151.0089.137.0%0.4%Materials
509496
₹1,328.25-0.7%77.3%₹228.2b₹1,589.6737.929.9%0.2%Capital Goods
9218
JP¥733.00-1.2%7.0%JP¥7.7bn/a32.428.9%1.4%Healthcare
Page 1 of 43